For example, a study conducted over a 20-year period involving approximately 2,000 patients has provided evidence indicating a higher cognitive impairment probability in individuals exhibiting recurrent elevations or progressive increases in interleukin (IL)-6 levels (18). The gene discussed is IL6; the disease is Cognitive impairment.